Search

Your search keyword '"Azzopardi, Nicolas"' showing total 42 results

Search Constraints

Start Over You searched for: Author "Azzopardi, Nicolas" Remove constraint Author: "Azzopardi, Nicolas"
42 results on '"Azzopardi, Nicolas"'

Search Results

1. Effect of the social environment on olfaction and social skills in WT and mouse model of autism

5. Effect of the social environment on olfaction and social skills in WT and a mouse model of autism

6. Confounding mitigation for the exposure‐response relationship of bevacizumab in colorectal cancer patients

9. Confounding mitigation for the exposure‐response relationship of bevacizumab in colorectal cancer patients.

10. Efficacy and safety of intravenous bevacizumab on severe bleeding associated with hemorrhagic hereditary telangiectasia: A national, randomized multicenter trial

17. The Airways, a Novel Route for Delivering Monoclonal Antibodies to Treat Lung Tumors

21. Skin inflammatory response and efficacy of anti-epidermal growth factor receptor therapy in metastatic colorectal cancer (CUTACETUX)

24. Crucial Role for Immune Complexes but Not FcRn in Immunization against Anti–TNF-α Antibodies after a Single Injection in Mice

25. Cetuximab pharmacokinetics influences overall survival in head and neck cancer patients

27. VEGF neutralizing aerosol therapy in primary pulmonary adenocarcinoma with K-ras activating-mutations

28. Influence of FCGR3A-158V/F Genotype and Baseline CD20 Antigen Count on Target-Mediated Elimination of Rituximab in Patients with Chronic Lymphocytic Leukemia: A Study of FILO Group

30. Significant effect of VEGFA polymorphisms on the clinical outcome of metastatic colorectal cancer patients treated with FOLFIRI-cetuximab

31. Pharmacocinétique des AcMo thérapeutiques en cancérologie digestive.

32. Dose – response relationship of bevacizumab in hereditary hemorrhagic telangiectasia

33. Aerosoltherapy for lung tumors using the monoclonal antibody cetuximab

35. Cetuximab Pharmacokinetics Influences Progression-Free Survival of Metastatic Colorectal Cancer Patients

38. Influence of FCGRTgene polymorphisms on pharmacokinetics of therapeutic antibodies

39. Significant effect of VEGFA polymorphisms on the clinical outcome of metastatic colorectal cancer patients treated with FOLFIRI-cetuximab

40. Fate of inhaled monoclonal antibodies after the deposition of aerosolized particles in the respiratory system

41. Trough infliximab concentration may predict long-term maintenance of infliximab in ankylosing spondylitis

42. Crucial Role for Immune Complexes but Not FcRn in Immunization against Anti-TNF-α Antibodies after a Single Injection in Mice.

Catalog

Books, media, physical & digital resources